Navigation Links
Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
Date:8/8/2013

CHESTERBROOK, Pa., Aug. 8, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Canaccord Genuity Growth Conference to be held August 14-15, 2013 at the Intercontinental Boston Hotel.  Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 3:30 p.m. ET on Thursday, August 15, 2013.  

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on August 15, 2013.  To access the live webcast, please log on to Auxilium's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.  The presentation replay will be available for ninety days after the event.About AuxiliumAuxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences.  Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in the U.S. and XIAFLEX® (collagenase clostridium histolyticum (CCH)) for the treatment of adult Dupuytren's contracture patients with a palpable cord in the U.S. Ferring International Center S.A. markets Testim in certain countries of the EU and Paladin Labs Inc. markets Testim in Canada.  Swedish Orphan Biovitrium AB has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in 71 Eurasian and African countries.  Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
2. Auxilium Pharmaceuticals to Announce Second Quarter 2013 Results and Conduct Conference Call on Thursday, August 1, 2013
3. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
4. Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare Conference
5. Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
6. Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
7. Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
8. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
9. Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
10. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
11. Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... VANCOUVER, Canada and HOUSTON, TX ... ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton ... have released from voluntary contractual lock-up (the "Lock-Up") 2,353,130 ... of the Common Shares originally subject to the Lock-Up. ... shares will be free trading immediately upon release from ...
(Date:2/27/2015)... , Feb. 27, 2015   Synageva BioPharma Corp. ... biopharmaceutical company developing therapeutic products for rare diseases, ... the European Organisation for Rare Diseases™ (EURORDIS™), The ... in observing Rare Disease Day. On ... organizations, industry, and other participants conduct special events ...
(Date:2/27/2015)... , Feb. 27, 2015  Organovo Holdings, Inc. ... focused on delivering breakthrough 3D bioprinting technology, announced ... Chief Executive Officer, will present live at VirtualInvestorConferences.com ... you to join us for this Company update," ... on our commercial launch of the exVive3D Liver, ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... Inc. (Pink Sheets:  TROV.PK), a developer of transrenal ... as head of commercial operations, effective April 16, ... diagnostic sales, marketing and operational experience. Most recently, ... at bioTheranostics, Inc.  McCormick served as a member ...
...  Faruqi & Faruqi, LLP, a leading national securities ... Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company") ... ) The investigation focuses ... federal securities laws by failing to disclose that: ...
Cached Medicine Technology:Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations 2Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm 2
(Date:2/27/2015)... Bethesda, MD (PRWEB) February 27, 2015 ... Foundation (Meso Foundation) and the National Cancer Institute ... Malignant Mesothelioma at the National Institutes of Health ... parts: one part is dedicated to medical professionals ... other is directed to the general public, including ...
(Date:2/27/2015)... Hills, CA (PRWEB) February 27, 2015 ... been chosen as their Sage ERP Document Management Partner ... Sage 300 ERP, Sage CRM and other complimentary solutions ... Global have worked side-by-side for many years to provide ... Sage ERP applications. , “We are thrilled to ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 In ... to the community by providing free dental care from ... has partnered with Dentistry from the Heart, and ... 11, 2015. The first 50 patients who are in ... they can’t afford, will have access to high­quality service ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... 2015 According to court documents, Donna ... June 25, 2013 and underwent a procedure during which ... mouth. Because the duodenoscope allegedly had not been ... “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A lawsuit ... County on behalf of Ms. Pirolli alleging that Lutheran ...
Breaking Medicine News(10 mins):Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2
... , Survey Measures Impact of Recession on Healthcare Use by ... Twenty-five percent of Americans say they had difficulty ... Baby Boomer and Generation X age groups leading the way, ... study, which tracks the impact of the recession on consumers, ...
... ... announces the launch of an anonymous, confidential survey to determine the extent of drowsy ... and Ship Captains. , ... New York, NY (Vocus) June 22, 2009 -- Snoring Isn,t Sexy ® ...
... , , BIRMINGHAM, England, June 21 ... June at the Rotary International Convention to recognize the humanitarian service ... work in support of the UN Millennium Development Goals. , ... , , Ban,s remarks are scheduled for the plenary session ...
... (ICD) have an ongoing risk of sudden incapacitation that ... Driving restrictions are imposed making these recommendations an ... recommendations for drivers with ICD,s was presented at a ... Germany on Sunday 21 June. A team ...
... proposal would be devastating to frail elderly and disabled ... The Ohio Skilled Nursing Care Coalition, consisting of the ... care for more than 80,000 frail elderly and disabled ... Governor Ted Strickland announced late Friday. , , ...
... experts stress that men shouldn,t take them with just this ... over-the-counter painkillers such as aspirin and ibuprofen might help men ... quick to caution men not to self-dose or to take ... side effects can result. , "Our data suggest if men ...
Cached Medicine News:Health News:Thomson Reuters Study Finds Baby Boomers and Generation X Face Healthcare Cost Hurdles 2Health News:Thomson Reuters Study Finds Baby Boomers and Generation X Face Healthcare Cost Hurdles 3Health News:Snoring Isn't Sexy, LLC Launches Survey to Determine Extent of Drowsy Drivers on Land, Sea and In The Air 2Health News:United Nations Secretary-General Ban Ki-moon to Keynote Rotary International's 100th Annual Meeting 2Health News:United Nations Secretary-General Ban Ki-moon to Keynote Rotary International's 100th Annual Meeting 3Health News:Implanted defibrillators: New recommendations for drivers with ICDs 2Health News:Painkillers May Be Good for the Prostate 2Health News:Painkillers May Be Good for the Prostate 3
... FalciVax is a two site ... for the detection of P. ... (Pf. HRP-2) and P. vivax ... also be used for specific ...
Malaria Pf. Assay Range...
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
Medicine Products: